- 全部删除
您的购物车当前为空
WK369是一种新型BCL6小分子抑制剂,具备出色的抗卵巢癌生物活性,能够诱导细胞周期停滞并引发细胞凋亡。WK369可直接结合BCL6-BTB结构域,并阻断BCL6与SMRT之间的相互作用,进而导致p53、ATR和CDKN1A的重新激活。
WK369是一种新型BCL6小分子抑制剂,具备出色的抗卵巢癌生物活性,能够诱导细胞周期停滞并引发细胞凋亡。WK369可直接结合BCL6-BTB结构域,并阻断BCL6与SMRT之间的相互作用,进而导致p53、ATR和CDKN1A的重新激活。

WK369 相关产品
| 产品描述 | WK369 is an innovative small molecule inhibitor of BCL6, demonstrating remarkable bioactivity against ovarian cancer by inducing cell cycle arrest and triggering apoptosis. It binds directly to the BCL6-BTB domain, obstructing the interaction between BCL6 and SMRT, which results in the reactivation of p53, ATR, and CDKN1A. |
| 分子式 | C19H20FN5O2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容